708 related articles for article (PubMed ID: 15703821)
1. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.
Masaki T; Tokuda M; Yoshida S; Nakai S; Morishita A; Uchida N; Funaki T; Kita Y; Funakoshi F; Nonomura T; Himoto T; Deguchi A; Kimura Y; Izuishi K; Wakabayashi H; Usuki H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
Int J Oncol; 2005 Mar; 26(3):661-71. PubMed ID: 15703821
[TBL] [Abstract][Full Text] [Related]
2. Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma.
Mohammad HS; Kurokohchi K; Yoneyama H; Tokuda M; Morishita A; Jian G; Shi L; Murota M; Tani J; Kato K; Miyoshi H; Deguchi A; Himoto T; Usuki H; Wakabayashi H; Izuishi K; Suzuki Y; Iwama H; Deguchi K; Uchida N; Sabet EA; Arafa UA; Hassan AT; El-Sayed AA; Masaki T
Int J Oncol; 2008 Dec; 33(6):1157-63. PubMed ID: 19020748
[TBL] [Abstract][Full Text] [Related]
3. Identification of c-Yes expression in the nuclei of hepatocellular carcinoma cells: involvement in the early stages of hepatocarcinogenesis.
Nonomura T; Masaki T; Morishita A; Jian G; Uchida N; Himoto T; Izuishi K; Iwama H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
Int J Oncol; 2007 Jan; 30(1):105-11. PubMed ID: 17143518
[TBL] [Abstract][Full Text] [Related]
4. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Nardone G; Romano M; CalabrĂ² A; Pedone PV; de Sio I; Persico M; Budillon G; Bruni CB; Riccio A; Zarrilli R
Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143
[TBL] [Abstract][Full Text] [Related]
5. Involvement of the theta-type protein kinase C in translocation of myristoylated alanine-rich C kinase substrate (MARCKS) during myogenesis of chick embryonic myoblasts.
Kim SS; Kim JH; Kim HS; Park DE; Chung CH
Biochem J; 2000 Apr; 347 Pt 1(Pt 1):139-46. PubMed ID: 10727412
[TBL] [Abstract][Full Text] [Related]
6. Genomic instability in chronic viral hepatitis and hepatocellular carcinoma.
Dore MP; Realdi G; Mura D; Onida A; Massarelli G; Dettori G; Graham DY; Sepulveda AR
Hum Pathol; 2001 Jul; 32(7):698-703. PubMed ID: 11486168
[TBL] [Abstract][Full Text] [Related]
7. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.
Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I
Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876
[TBL] [Abstract][Full Text] [Related]
8. 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
Chuma M; Hige S; Nakanishi M; Ogawa K; Natsuizaka M; Yamamoto Y; Asaka M
J Gastroenterol Hepatol; 2008 Sep; 23(9):1431-6. PubMed ID: 18854000
[TBL] [Abstract][Full Text] [Related]
9. Thrombin-induced phosphorylation of the myristoylated alanine-rich C kinase substrate (MARCKS) protein in bovine pulmonary artery endothelial cells.
Zhao Y; Davis HW
J Cell Physiol; 1996 Nov; 169(2):350-7. PubMed ID: 8908202
[TBL] [Abstract][Full Text] [Related]
10. GADD45-alpha expression in cirrhosis and hepatocellular carcinoma: relationship with DNA repair and proliferation.
Gramantieri L; Chieco P; Giovannini C; Lacchini M; Treré D; Grazi GL; Venturi A; Bolondi L
Hum Pathol; 2005 Nov; 36(11):1154-62. PubMed ID: 16260267
[TBL] [Abstract][Full Text] [Related]
11. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
[TBL] [Abstract][Full Text] [Related]
12. Impact of hepatitis B virus (HBV) X gene integration in liver tissue on hepatocellular carcinoma development in serologically HBV-negative chronic hepatitis C patients.
Toyoda H; Kumada T; Kaneoka Y; Murakami Y
J Hepatol; 2008 Jan; 48(1):43-50. PubMed ID: 18023912
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma.
El-Bassiouni A; Nosseir M; Zoheiry M; El-Ahwany E; Ghali A; El-Bassiouni N
APMIS; 2006 Jun; 114(6):420-7. PubMed ID: 16856963
[TBL] [Abstract][Full Text] [Related]
14. CD81 nucleotide mutation in hepatocellular carcinoma and lack of CD81 polymorphism in patients at stages of hepatitis C virus infection.
Itakura J; Nagayama K; Enomoto N; Sakamoto N; Tazawa J; Izumi N; Marumo F; Sato C
J Med Virol; 2001 Jan; 63(1):22-8. PubMed ID: 11130883
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease-free survival in patients with hepatocellular carcinoma.
Kondo M; Yamamoto H; Nagano H; Okami J; Ito Y; Shimizu J; Eguchi H; Miyamoto A; Dono K; Umeshita K; Matsuura N; Wakasa K; Nakamori S; Sakon M; Monden M
Clin Cancer Res; 1999 Dec; 5(12):4005-12. PubMed ID: 10632332
[TBL] [Abstract][Full Text] [Related]
16. Alterations of the fragile histidine triad gene in hepatitis C virus-associated hepatocellular carcinoma.
Zekri AR; Bahnassy AA; Hafez M; El-Shehaby AM; Sherif GM; Khaled HM; Zakhary N
J Gastroenterol Hepatol; 2005 Jan; 20(1):87-94. PubMed ID: 15610452
[TBL] [Abstract][Full Text] [Related]
17. Mutations in the E2-PePHD region of hepatitis C virus type 1b in patients with hepatocellular carcinoma.
Bagaglio S; De Mitri MS; Lodrini S; Paties C; Cassini R; Bianchi G; Bernardi M; Lazzarin A; Morsica G
J Viral Hepat; 2005 May; 12(3):243-50. PubMed ID: 15850464
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection of ras oncogene p21 product in liver cirrhosis and hepatocellular carcinoma.
Nonomura A; Ohta G; Hayashi M; Izumi R; Watanabe K; Takayanagi N; Mizukami Y; Matsubara F
Am J Gastroenterol; 1987 Jun; 82(6):512-8. PubMed ID: 3034055
[TBL] [Abstract][Full Text] [Related]
19. Expression of c-kit protooncogen in hepatitis B virus-induced chronic hepatitis, cirrhosis and hepatocellular carcinoma: has it a diagnostic role?
Kara B; Doran F; Kara IO; Akkiz H; Sandikci M
Int J Clin Pract; 2008 Aug; 62(8):1206-11. PubMed ID: 18284441
[TBL] [Abstract][Full Text] [Related]
20. Expression of gap junction protein connexin32 in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.
Nakashima Y; Ono T; Yamanoi A; El-Assal ON; Kohno H; Nagasue N
J Gastroenterol; 2004 Aug; 39(8):763-8. PubMed ID: 15338370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]